Radiopharmaceuticals for WBAMC
Closed Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- W81K0025QA241
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Fort Bliss, Texas 79918, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command is procuring radiopharmaceuticals for delivery to the Nuclear Medicine Section at William Beaumont Army Medical Center (WBAMC) in Fort Bliss, Texas. The solicitation requires five specific radiopharmaceutical products including DAT Scan Ioflupane, Indium Oxine, Ceretec kit, Adreview, and MPI Indium DTPA IN 111, with quantities ranging from 1 to 46 units depending on the line item. All radiopharmaceuticals must comply with U.S. Pharmacopeia guidelines, and the contractor must be accredited by the Joint Commission, with received dose activity required to be within 5% of the calibrated dose activity. The evaluation will follow a lowest-priced, technically acceptable source selection process, requiring offerors to submit both technical proposals and demonstrate compatibility with government-owned attachments and original equipment manufacturer authorization. The contract delivery deadline is October 1, 2025, with quotes due by September 9, 2025.
This opportunity is set aside for Women-Owned Small Business (WOSB) enterprises, though the main solicitation notice indicates "No Set-Aside Used," creating a discrepancy between the primary notice and the detailed RFQ document. The contract will be awarded on a firm fixed price basis, with the contractor responsible for all transportation costs to deliver the radiopharmaceuticals to WBAMC's Nuclear Medicine Section. Performance will take place at Fort Bliss, Texas, with the specific delivery location being the Nuclear Medicine Section at William Beaumont Army Medical Center. The solicitation does not identify any current incumbents or provide specific budget ranges, focusing instead on the technical requirements and delivery specifications for these specialized medical products. The tight timeline between the posting date of September 5, 2025, and the quote deadline of September 9, 2025, suggests this may be an urgent procurement need for the medical facility.
Notice text
WBAMC pharmaceuticals.
Files
| File | Type | Posted |
|---|---|---|
| W81K0025QA241.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Radiopharmaceuticals for WBAMC | Award Notice | |
| Radiopharmaceuticals for WBAMC | Solicitation | |
| This notice | Solicitation | |
| Radiopharmaceuticals for WBAMC | Pre-Solicitation | |
| Radiopharmaceuticals for WBAMC | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | Veterans Integrated Service Network 10 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity